Skip to content

    Shree Pushkar Chemicals & Fertilisers Limited

    SHREEPUSHK
    Chemicals·19 May 2025
    Management Summary

    Shree Pushkar Chemicals & Fertilisers reported a strong Q4 and full year FY25, marked by robust revenue and profit growth, margin expansion, and strategic capacity additions. Despite a temporary volume dip in the Chemicals segment due to an extended plant shutdown, the company maintained a positive outlook, driven by operational efficiencies and a healthy balance sheet. Management provided optimistic guidance for FY26, projecting significant revenue and PAT margin improvements.

    Highlights

    5
    • Q4 FY25 revenue from operations increased 15% YoY to ₹219.4 crores, driven by 19% growth in Chemicals and 10.6% in Fertilizers.

    • EBITDA for Q4 FY25 grew 32% to ₹24.70 crores, with margins expanding to 11.3% due to operational efficiencies.

    • Full Year FY25 PAT surged 58% to ₹58.60 crores, supported by volume growth, price discipline, and stable costs.

    • Successfully commissioned an additional 3.8 MW DC solar power plant, bringing total capacity to 9 MW DC, and initiated work on a 10 MW DC plant in Nanded.

    • Completed cumulative CAPEX of ₹202 crores entirely through internal accruals, with a further planned CAPEX of ₹160 crores underway.

    Concerns

    3
    • Chemical division volumes declined 11% YoY in Q4 FY25 to 10,026 metric tons, primarily due to an extended acid complex shutdown of 52-53 days.

    • Significant inventory buildup, particularly of rock phosphate, due to pre-buying for the fertilizer season, which could impact working capital utilization.

    • Uncertainty regarding the BIS deferment for K-acid and Vinyl Sulphone, though management downplays immediate impact.

    What Changed2

    vs Q1 FY26

    Guidance items7 → 9 (+2)Risks discussed3 → 4 (+1)
    Key financials

    Metrics

    7

    Periods

    2

    Q4 FY25

    4
    • Revenue
      ₹219.4 Cr
      YoY+15%
    • EBITDA
      ₹24.7 Cr
      YoY+32%
    • EBITDA Margin
      11.3%
    • PAT
      ₹16.5 Cr
      YoY+27%

    FY25

    3
    • Revenue
      ₹806.3 Cr
      YoY+11%
    • EBITDA
      ₹83.9 Cr
      YoY+38%
    • PAT
      ₹58.6 Cr
      YoY+58.0%

    Segment breakdown

    • Chemicals (Q4 FY25)10,026 metric tons2.6%
    • Fertilizer (Q4 FY25)60,000 metric tons15.5%
    • Chemicals (FY25)56,626 metric tons14.6%
    • Fertilizer (FY25)2,61,000 metric tons67.3%
    Donut· Share of Volume

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹160 crores

    entirely through internal accruals

    Debt

    Debt disclosed

    Liquidity

    Cash ₹109.6 crores

    Net cash from operations improved significantly to Rs. 37.5 crores from Rs. 16.2 crores in FY '24, driven by improved profitability and efficient capital management.

    Guidance & targets

    9
    CategoryTargetPriority
    Revenue
    Total Revenue
    ₹950-1,000 crores
    Medium
    Revenue
    Unit-6 Revenue Potential
    ₹450 crores
    Medium
    Profitability
    PAT Margin
    8.25-8.5%
    Medium
    Revenue Growth
    Overall Revenue Growth
    at least 20%
    Medium
    Capacity Utilization
    Unit-5 Operational Efficiency
    operational efficiency
    High
    Capacity Expansion
    Unit-6 Trial Production
    trial production
    High
    Fertilizer Volume
    Fertilizer Sales Volume
    150,000 tons
    Medium
    Fertilizer Volume Growth
    Fertilizer Business Growth
    20%
    Medium
    Tax Rate
    Effective Tax Rate
    16-17%
    High

    Chemical segment volume recovery

    Q1 FY26
    Current11% decline in Q4 FY25
    TargetVolumes back on track with better pricing

    Why it matters

    Recovery of the Chemical segment is crucial for overall revenue growth and margin improvement, especially after the extended acid plant shutdown.

    So, you are saying it is completed and now working properly, so we should see the full benefit of this pricing in this quarter? Yes. And now that impact will be in Q1 of this current financial year.

    How to verify

    key_financials.segment_breakdown[name='Chemicals (Q1 FY26)'].metrics[label='Volume']

    Risks & concerns

    4
    RiskSeverity

    Extended acid complex shutdown impacting Chemical segment volumes

    Acid complex shutdown lasted 52-53 days instead of the usual 30-35 days, leading to an 11% decline in Chemical segment volumes in Q4 FY25.Management acknowledged

    medium

    Inventory buildup due to raw material pre-buying

    Excessive rock phosphate was purchased in Feb/Mar for the coming fertilizer season, leading to inventory buildup, though management views it as a strategic move due to low prices.Management acknowledged

    medium

    Uncertainty from BIS deferment for K-acid and Vinyl Sulphone

    BIS deferment for K-acid (till May 2026) and Vinyl Sulphone (3 months) is not expected to have a major impact due to current market conditions and lack of Chinese imports.Analyst downplayed

    low

    Geopolitical risks impacting Bangladesh sales

    Sales to Bangladesh constitute only 4% of total business, and management believes any disturbance would be short-term and manageable through diversification to other markets.Analyst downplayed

    low

    Q&A highlights

    8

    “Let us divide this question in two different parts. A, that the Chemical business has gone down tremendously. Chemical business includes our acid complex also. And let me tell you, Prit, especially this particular time, this particular year, unfortunately our shutdown continued for almost two to two and a half months in our acid complex. ... Now B, coming to your inventory levels. We have bought a sufficient rock phosphate, particularly for the coming season of fertilizers in the month of February and March.”

    Addresses the reasons for Q4 chemical volume decline and inventory increase, linking it to an extended plant shutdown and strategic raw material pre-buying.

    asked by Prit Nagersheth

    3 min read6 chapters

    Detailed Narrative

    01

    Q4 and Full Year FY25 Performance Overview

    Shree Pushkar Chemicals & Fertilisers reported a strong Q4 FY25 with revenue from operations reaching ₹219.4 crores, a 15% year-on-year increase. EBITDA for the quarter grew 32% to ₹24.70 crores, with margins expanding to 11.3%. Profit after tax increased 27% to ₹16.5 crores. For the full year FY25, the company achieved revenues of ₹806.3 crores, an 11% increase over FY24. EBITDA improved 38% to ₹83.90 crores, and net profit moved up 58% to ₹58.60 crores, reflecting a PAT margin of 7.2%.

    02

    Segmental Performance and Volume Dynamics

    In Q4 FY25, the Chemical division registered a 19% revenue growth, while the Fertilizer division advanced by 10.6%. However, Chemical segment volumes declined 11% year-on-year to 10,026 metric tons in Q4, primarily due to an extended acid complex shutdown of 52-53 days. Conversely, the Fertilizer segment recorded a 5% increase in volume to 60,000 metric tons for Q4. For the full year, Fertilizer volumes grew 24% to 2.61 lakh metric tons, while Chemical volumes remained relatively stable at 56,626 metric tons, marginally lower by 1%.

    03

    Strategic Capex and Capacity Expansion

    The company completed a cumulative CAPEX of ₹202 crores, entirely funded through internal accruals, focusing on manufacturing capacity expansion and value chain integration. A further planned CAPEX of ₹160 crores is underway, with ₹72 crores already incurred as of March 31, 2025. This includes the commissioning of an additional 3.8 MW DC solar power plant, bringing total solar capacity to 9 MW DC, and initiating work on a 10 MW DC solar plant in Nanded for captive consumption. The new Unit-5 dyes unit is expected to achieve operational efficiency in the last six months of FY26, and Unit-6 NPK complex is targeted for trial production by mid-October/November 2025, with a revenue potential of ₹450 crores annually once operational.

    04

    Balance Sheet Strength and Capital Management

    Shree Pushkar maintains a strong balance sheet with a net cash positive position, backed by ₹116.55 crores of non-lien deposits. The equity base increased to ₹538.9 crores, and the company closed the year with ₹109.6 crores in investment and cash balance. Net cash from operations significantly improved to ₹37.5 crores from ₹16.2 crores in FY24, driven by enhanced profitability and efficient capital management. Finance costs for FY25 were minimal at ₹2.3 crores, representing only 0.25% of total revenue, reflecting a low leverage position and no long-term borrowings for new CAPEX.

    05

    Outlook and Guidance for FY26

    Management projects total revenue for FY26 to be in the range of ₹950-1,000 crores, indicating at least 20% growth. The PAT margin is expected to improve to 8.25-8.5% for the current financial year. The Fertilizer segment is anticipated to achieve at least 20% volume growth, targeting around 150,000 tons for the current season, driven by DAP shortages and increased SSP subsidies. The effective tax rate for FY26 is expected to remain similar to FY25, around 16-17%.

    06

    Market Dynamics and Raw Material Strategy

    The phosphatic fertilizer market is experiencing a global shortage, with DAP prices rising significantly, creating a favorable environment for SSP. The company strategically pre-bought rock phosphate in February and March when prices were at a low, leading to inventory buildup but securing raw materials at competitive rates. In the Chemical segment, management notes improving prices and reduced competition from China, especially with the impending BIS regulations, despite deferments for K-acid and Vinyl Sulphone.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.